Calls for Domperidone Ban Intensify as Link to Premature Deaths Surfaces
Posted By Caspian Braxton On 22 Mar 2024 Comments (0)
The independent journal Prescrire has demanded the removal of domperidone, marketed as Motilium, from the European market. This call to action is spurred by the medication's association with cardiac risks and premature deaths, despite its effectiveness in treating nausea and vomiting. Alternative treatments are being recommended.
READ MORE